Correlation between MGMT promoter methylation and response to temozolomide-based therapy in neuroendocrine neoplasms: an observational retrospective multicenter study
2017; Springer Science+Business Media; Volume: 60; Issue: 3 Linguagem: Inglês
10.1007/s12020-017-1474-3
ISSN1559-0100
AutoresDavide Campana, Thomas Walter, Sara Pusceddu, Fabio Gelsomino, Emmanuelle Graillot, Natalie Prinzi, Andrea Spallanzani, Michelangelo Fiorentino, Marc Barritault, Filippo Gustavo Dall’Olio, Nicole Brighi, Guido Biasco,
Tópico(s)Brain Metastases and Treatment
Referência(s)